SCHEMBL7707463

SCHEMBL7707463

NC(=O)c1ccccc1Oc1ccc(N2CCOCC2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.51
CYP1A2 P05177 2/20 0.51
CTNNB1 P35222 1/20 0.48
SYK P43405 1/20 0.48
ALDH1A1 P00352 2/20 0.46
CNR2 P34972 1/20 0.44
NPC1 O15118 2/20 0.44
AURKA O14965 1/20 0.44
RPS6KB1 P23443 1/20 0.44
AKT1 P31749 1/20 0.44
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44
KDM4E B2RXH2 2/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
DGAT1 O75907 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2169026 0.78 CNR2 (0.64) RAB9ACYP1A2SYKALDH1A1CNR2
SCHEMBL28940962 0.77 ALDH1A1 (0.55) RAB9ACYP1A2ALDH1A1CNR2NPC1
SCHEMBL6630091 0.73 CTNNB1 (0.59) RAB9ACTNNB1KDM4ELMNAMAPT
SCHEMBL6628177 0.73 CTNNB1 (0.59) RAB9ACTNNB1KDM4ELMNASMN1; SMN2
SCHEMBL357927 0.73 ALDH1A1 (0.71) CYP1A2ALDH1A1KDM4EPOLBHPGD
SCHEMBL27766592 0.72 ALDH1A1 (0.55) RAB9ACYP1A2ALDH1A1CNR2NPC1
SCHEMBL2852915 0.72 ALDH1A1 (0.55) RAB9ACYP1A2ALDH1A1CNR2NPC1
Hydrochloric Acid SCHEMBL5013604 0.72 ALDH1A1 (0.69) CYP1A2ALDH1A1KDM4EPOLBHPGD
SCHEMBL5739985 0.71 PKM (0.51) RAB9ACYP1A2ALDH1A1NPC1AKT1
SCHEMBL6628686 0.71 CTNNB1 (0.56) RAB9ACYP1A2CTNNB1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002016357-A2 QUINUCLIDINE-SUBSTITUTED ARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed